chris brightling

Professor and Honorary Consultant

University of Leicester

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Immunology Immunology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Chris Brightling is a faculty member at the University of Leicester in the United Kingdom. He serves as an Honorary Consultant and focuses his research on respiratory medicine, specifically in the areas of asthma, COVID-19 treatment, and immune responses in respiratory conditions. His recent publications include significant studies on the efficacy of various treatments for severe asthma and critical insights into the management of COVID-19 patients.

Articles (10)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (27)

William Ricketts

Honorary Senior Lecturer

Queen Mary University of London

UNITED KINGDOM

chris brightling

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Alterations in T and B cell function persist in convalescent COVID-19 patients

The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study.

Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma.

Treating severe asthma: targeting the IL-5 pathway.

Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: a randomized clinical trial.

Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline.

The pharmacology of the prostaglandin D<sub>2</sub> receptor 2 (DP<sub>2</sub>) receptor antagonist, fevipiprant.

Research priorities for Long Covid: refined through an international multi-stakeholder forum.

Collaborators (27)

William Ricketts

Tim Old

Stefania Principe

Vishal Dey

Nawar Diar Bakerly

Hayley Colton

Eleanor Mishra

chris imray

Emmanuelle Denis

Claire Madelaine

John Grainger

Polly Black

N. A. Kametas

Huzaifa Adamali

Lyrics Noba

Tovah Shaw

James D. Chalmers

Beatriz Duran Jimenez

Martin Landray

Geeshath Jayasekera

Sean Knight

Charitini Stavropoulou

Søren Kudsk‐Iversen

Syed Murtuza Baker

Tom Dymond

Madhvi Menon

Laurence Pearmain

Make your next move.